Navigation Links
New Study of Primary Liver Cancer Seeks to Enroll 400 French Patients
Date:2/3/2012

PARIS, February 3, 2012 /PRNewswire/ --

'SARAH' - a French national collaborative randomized controlled trial of radioembolization with yttrium-90 resin microspheres versus sorafenib in advanced hepatocellular carcinoma is now open for recruitment

The start of SARAH, a new randomized controlled trial to directly compare the effectiveness of radioembolization with yttrium-90 resin microspheres (SIR-Spheres® microspheres; Sirtex Medical Limited, Australia) versus sorafenib (Nexavar®, Bayer HealthCare Pharmaceuticals, Germany), a systemic therapy that is the current standard of care for patients with non-surgical advanced hepatocellular carcinoma (HCC), was announced today by the principal investigator, Professor Valérie Vilgrain MD, PhD, Department of Radiology, Beaujon Hospital, Assistance Publique - Hôpitaux de Paris, Clichy and Université Paris Diderot, Sorbonne Paris Cité, France.

SARAH (SorAfenib versus Radioembolization in Advanced Hepatocellular carcinoma)is a Phase III multi-centre prospective randomized open-labelled trial, which aims to recruit 400 patients in France with advanced HCC (Barcelona Clinic Liver Cancer stage C) with or without portal vein thrombosis and no extrahepatic spread, who are ineligible for surgical resection, liver transplantation or radiofrequency ablation; or whose disease has progressed or recurred after previous therapies.[1]

The primary goal of the study will be to assess if radioembolization with yttrium-90 resin microspheres provides an increased survival benefit compared to sorafenib in patients with advanced HCC.

Professor Vilgrain said: "Around 20 specialist cancer centres throughout France will be involved in this trial. SIR-Spheres microspheres were selected for the test arm of this collaborative trial, which is being promoted by the 'Assistance Publique - Hôpitau
'/>"/>

SOURCE Sirtex Medical Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Stryker Presents Results of the TREVO Prospective Clinical Study at the International Stroke Conference
2. Aria Announces Publication of Independent Study in the American Journal of Obstetrics & Gynecology Using Arias Technology
3. Study Highlights CyberKnife SBRT Benefits for Treatment of Central Lung Tumors
4. Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX® Phase Ib Cellulite Study
5. Kaiser Permanente Study Finds Gardasil Does Not Trigger Lupus, Rheumatoid Arthritis or Type 1 Diabetes After Vaccination
6. Study Data Show CUVPOSA® Reduced Chronic Severe Drooling in Patients Ages 3-16 Years-Old with Neurologic Conditions
7. West Wireless Health Institute Launches Groundbreaking Research Study on Sense4Baby™ Fetal Monitoring Device in Mexico
8. Recent Study Reveals Benefits to Women From DHEA Hormone
9. UH Case Medical Center the First in Region to Enroll Patients in Worldwide Study
10. BioElectronics Study on Plantar Fasciitis to be Published in The Journal of Foot and Ankle Surgery
11. Journal of Cardiovascular Electrophysiology Study Shows Promising Single Ablation Procedure Outcomes With HeartLight EAS for Treatment of Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... DIEGO , Oct. 20, 2014 ... industry leader in bioactive lipid-targeted therapeutics, received official notification ... has been granted another key patent supporting its ... newly issued patent, European patent No. 2087002, claims ... substance in Lpath,s two lead compounds, iSONEP and ...
(Date:10/20/2014)... Mary,s Medicinals today announced that its 501(c)(3) foundation, ... Operation Grow4Vets , a national, nonpartisan organization focused ... to assist them in living with injuries sustained while ... , An ever-increasing number of medical studies have shown ... pain, Post-traumatic Stress Disorder (PTSD) and Traumatic Brain Injury ...
(Date:10/20/2014)... N.C., Oct. 20, 2014  BioPontis Alliance for ... both philanthropies, announced today the creation of a ... treatment of the rare disease known as Charcot- ... its alliance model earlier this month. Today,s partnership ... a collaborative model where researchers and all CMT ...
Breaking Medicine Technology:Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 2Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 4Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets 2Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets 3The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 2The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 3
... On July 31 , Massachusetts lawmakers passed legislation ... sentencing laws. , , , ... Drug offenders serving mandatory minimum sentences at county Houses of Correction will ... bill lawmakers voted on did not include two reforms previously endorsed by ...
... Conatus Pharmaceuticals Inc. announced today that Conatus acquired the Idun Pharmaceuticals ... a privately-held drug development company focused on liver disease and oncology. ... Conatus Pharmaceuticals ... of Idun Pharmaceuticals, which was acquired by Pfizer Inc. in 2005.  "The ...
Cached Medicine Technology:FAMM Applauds Massachusetts Legislature for Sentencing Reforms 2Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary 2
(Date:10/20/2014)... (PRWEB) October 20, 2014 My Clients ... management software application. The new module enables easy ... receive full life-cycle quality care. , This application allows ... within their practice, attach a to-do item to a ... and even set up reoccurring reminders for follow-ups. ...
(Date:10/20/2014)... Rockynol Retirement Community broke ground on ... $11 million project will include the latest in Assisted ... full-service restaurant style dining. , “We are excited to ... Living apartments,” said Kara Hanzie, Rockynol Executive Director during ... care and this investment is proof of our commitment.” ...
(Date:10/20/2014)... 20, 2014 Final Cut Pro X Plugin ... the Citrus theme for FCPX filmmakers . , “Fun, ... describe the Citrus theme” Says Christina Austin, CEO of Pixel ... so professional.” , Citrus comes with all the tools needed ... are: four transitions for added style, a title screen for ...
(Date:10/20/2014)... Houston, Texas (PRWEB) October 20, 2014 ... invited to present the key elements of his innovative ... visiting professor to plastic surgery residents and faculty at ... (UTMB) , where he, too, was once a medical ... of the largest private cosmetic plastic surgery practices in ...
(Date:10/19/2014)... Recently, BambooIndustry.com, one of the most ... range of bamboo deckings . Moreover, the company ... they are now available at deeply discounted rates. ... hard to overstate the significance of online business nowadays. ... services. The company’s workers are striving to deliver both ...
Breaking Medicine News(10 mins):Health News:My Clients Plus Announces New Workflow Management Software 2Health News:Rockynol Retirement Community Expands Assisted Living Center 2Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2
... Leading Researchers to Discuss, State of Breast Cancer ... BOSTON, April 9 The Massachusetts Affiliate of Susan ... 10 at Harvard Medical,School, featuring some of the nation,s ... recent advances in breast,cancer research and the need for ...
... April 9, 2008 A company founded by an,industry ... and Canada sales,and distribution outlet for the Japanese "Paro" ... (ISC) of Japan, announced,today at the RoboBusiness Conference & ... Inc., founded by Walter Weisel, began its development,through a ...
... global clinical,research organization, is pleased to announce that it ... CRO,s in Las Vegas, Nevada from April,14 to the ... of its executive team and employees. Chiltern will be ... at 2:45 pm -- Track: Relationship Management Resource ...
... suggests that a genetic fingerprint associated with normal embryonic ... function of cancer stem cells. The research, published by ... Stem Cell, demonstrates that embryonic stem cells and multiple ... pattern that is repressed in normal differentiated cells, a ...
... ability to stabilize blood-brain barrier may play role in ... A little caffeine every day could offer some protection ... , Rabbits given the daily caffeine equivalent of one ... 12 weeks suffered relatively little damage in their blood-brain ...
... (MDC), a privately-owned chain of dental clinics in ... Dental Center, has reached,a settlement with the United ... allegations, the Justice Department announced today. Under the,agreement, ... that it,caused false or fraudulent claims for payment ...
Cached Medicine News:Health News:Massachusetts Affiliate of Susan G. Komen for the Cure to Spotlight Gaps in Breast Cancer Research 2Health News:'Paro,' the Baby Seal Service Robot From Japan, Finds a New Home in the United States With Help From JETRO 2Health News:Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CRO's Meeting in Las Vegas, April 14 - 16, 2008. 2Health News:Module map links embryonic stem cells and cancer stem cells 2Health News:Caffeine May Block High Cholesterol Linked to Alzheimer's 2Health News:North Carolina Dental Services Chain Pays $10 Million to Resolve False Claims Allegations 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: